BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vrsalović M, Presečki AV. Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: A meta-analysis of prospective studies. Clin Cardiol 2017;40:1231-5. [PMID: 29243858 DOI: 10.1002/clc.22813] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS;  American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e56-e528. [PMID: 30700139 DOI: 10.1161/cir.0000000000000659] [Cited by in Crossref: 2988] [Cited by in F6Publishing: 1467] [Article Influence: 996.0] [Reference Citation Analysis]
2 Kristić I, Crnčević N, Runjić F, Čapkun V, Polašek O, Matetic A, Vrsalovic M. ACEF performed better than other risk scores in non-ST-elevation acute coronary syndrome during long term follow-up. BMC Cardiovasc Disord 2021;21:70. [PMID: 33535979 DOI: 10.1186/s12872-020-01841-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Meng Q, Cen Z. New oral anticoagulants for nonvalvular atrial fibrillation with peripheral artery disease: a meta-analysis. Herz 2021;46:352-8. [DOI: 10.1007/s00059-020-04970-8] [Reference Citation Analysis]
4 Miao B, Hernandez AV, Roman YM, Alberts MJ, Coleman CI, Baker WL. Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation. Clin Cardiol 2020;43:524-31. [PMID: 32106334 DOI: 10.1002/clc.23344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
5 Koivunen V, Juonala M, Mikkola K, Hakovirta HH. CHRONIC LIMB THREATENING ISCHEMIA AND DIABETES MELLITUS: THE SEVERITY OF TIBIAL ATHEROSCLEROSIS AND OUTCOME AFTER INFRAPOPLITEAL REVASCULARIZATION. Scand J Surg 2020;:1457496920968679. [PMID: 33225841 DOI: 10.1177/1457496920968679] [Reference Citation Analysis]
6 Kamil S, Sehested T, Houlind K, Lassen J, Gislason G, Dominguez H. Time trends in the risk of atrial fibrillation and ischaemic stroke in patients with peripheral artery disease between 1997 and 2015. Open Heart 2020;7:e001185. [PMID: 32354739 DOI: 10.1136/openhrt-2019-001185] [Reference Citation Analysis]
7 Vrsalovic M. Arterial stiffness: A helpful guide to prognosis and therapy in populations with a high baseline cardiovascular risk. J Clin Hypertens 2018;20:1294-5. [DOI: 10.1111/jch.13362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 González-Fajardo JA, Ansuategui M, Romero C, Comanges A, Cases C, Gómez-Arbeláez D. Atrial Fibrillation and Surgical Patients with Peripheral Arterial Disease. Ann Vasc Surg 2020;67:411-6. [PMID: 32209417 DOI: 10.1016/j.avsg.2020.02.035] [Reference Citation Analysis]
9 Zhu J, Tan X, Zhou JZ. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A systematic review and meta-analysis. Clin Cardiol 2021;44:1050-7. [PMID: 34170015 DOI: 10.1002/clc.23678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Bhandari N, Newman JD, Berger JS, Smilowitz NR. Diabetes Mellitus And Outcomes Of Lower Extremity Revascularization For Peripheral Artery Disease. Eur Heart J Qual Care Clin Outcomes 2020:qcaa095. [PMID: 33351089 DOI: 10.1093/ehjqcco/qcaa095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Vrsalović M, Presečki AV. Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: A meta-analysis of prospective studies. Clin Cardiol 2017;40:1231-5. [PMID: 29243858 DOI: 10.1002/clc.22813] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
12 Vitalis A, Nirantharakumar K, Thayakaran R, Vohra RK, Kay M, Shantsila A, Lip GYH. THE IMPACT OF ATRIAL FIBRILLATION ON OUTCOMES OF PERIPHERAL ARTERIAL DISEASE: ANALYSIS OF ROUTINELY COLLECTED PRIMARY CARE DATA. Am J Med 2021:S0002-9343(21)00733-6. [PMID: 34793748 DOI: 10.1016/j.amjmed.2021.10.021] [Reference Citation Analysis]
13 Lee SL, Ong TJ, Mazlan-Kepli W, Mageswaran A, Tan KH, Abd-Malek AM, Cronshaw R. Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic. World J Cardiol 2021; 13(9): 483-492 [PMID: 34621493 DOI: 10.4330/wjc.v13.i9.483] [Reference Citation Analysis]
14 Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW;  American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020;141:e139-e596. [PMID: 31992061 DOI: 10.1161/cir.0000000000000757] [Cited by in Crossref: 1624] [Cited by in F6Publishing: 907] [Article Influence: 812.0] [Reference Citation Analysis]
15 Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Lewis TT, Liu J, Loop MS, Lutsey PL, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, VanWagner LB, Wang NY, Tsao CW;  American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143:e254-e743. [PMID: 33501848 DOI: 10.1161/cir.0000000000000950] [Cited by in Crossref: 174] [Cited by in F6Publishing: 116] [Article Influence: 174.0] [Reference Citation Analysis]